Author:
Segawa Ivan,Bakeera-Kitaka Sabrina,Ssebambulidde Kenneth,Muwonge Timothy R.,Oriokot Lorraine,Ojiambo Kevin Ouma,Mujugira Andrew
Abstract
Abstract
Background
Adolescent girls and young women (AGYW) at institutions of higher learning are at high risk of HIV, and conventional HIV testing services may not reach them sufficiently. HIV self-testing (HIVST) scalability can be informed by identifying AGYW who have used or are interested in using HIVST. We aimed to determine factors associated with use and willingness to use HIVST among female university students.
Methods
An online cross-sectional survey was conducted among 483 female students at Makerere University, Uganda. Proportions of students who have used or are willing to use HIVST and their associated factors were determined. Modified Poisson regression models were used to estimate prevalence ratios (PR) and their 95% confidence intervals (CI).
Results
The median age of the participants was 22 (Interquartile range [IQR] 21–23) years, and 21% had never tested for HIV. Over 93% were willing to utilize HIVST, and 19% had ever used HIV self-test kits. Increasing age (adjusted prevalence ratio [aPR] 1.23 per year, 95% CI 1.07–1.43) was significantly associated with HIVST use. Predictors of willingness to self-test for HIV were college type (arts vs. science-based, aPR 0.92, 95% CI 0.88–0.97), number of sexual partners (one, aPR 1.07, 95% CI 1.03–1.12 or ≥ 2, aPR 1.08, 95% CI 1.04–1.19, vs. none), alcohol (aPR 1.04, 95% CI: 1.00–1.09) or injection drug (aPR 1.04, 95% CI 1.00–1.09) use, a history of sexually transmitted infections in past 12 months (aPR 1.05, 95% CI 1.01–1.09), and HIV testing experience (tested in past 12 months, aPR 1.12, 95% CI 1.02–1.22 or over 12 months, aPR 1.13, 95% CI 1.03–1.24, vs. never tested).
Conclusion
HIVST was highly acceptable despite its limited use. This study demonstrates female student characteristics that can be leveraged to scale up HIVST programs in higher institutions of learning.
Funder
Government of Uganda through Makerere University Research and Innovations Fund
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Virology,Molecular Medicine
Reference29 articles.
1. UNAIDS report. IN DANGER: UNAIDS global AIDS update 2022. Geneva: Joint United Nations Programme on HIV/
AIDS; 2022. Licence: CC BY-NC-SA 3.0 IGO. https://www.unaids.org/sites/default/files/media_asset/2022-global-aids-update_en.pdf.
2. Fact sheet. Uganda AIDS Commission. Facts on HIV and AIDS in Uganda based on data ending 31st Dec 2020. 2021. https://uac.go.ug/media/attachments/2021/09/13/final-2021-hiv-aids-factsheet.pdf.
3. PrEP brief. WHO Implementation tool for pre-exposure prophylaxis (PrEP) of HIV infection. Module 12: Adolescents
and young adults. Geneva: World Health Organization; 2018. Licence: CC BY-NC-SA 3.0 IGO. https://apps.who.int/iris/bitstream/handle/10665/273172/WHO-CDS-HIV-18.13-eng.pdf?sequence=1&isAllowed=y.
4. MoH press release. Ministry of Health. Release of preliminary results of the 2020 Uganda population HIV impact assessment. Kampala; 2022. https://www.mediacentre.go.ug/sites/default/files/media/MOH%20Statement_0.pdf.
5. UNAIDS report. Joint United Nations Programme on HIV/AIDS (UNAIDS). UNAIDS Data 2020. Geneva; 2020. https://www.unaids.org/sites/default/files/media_asset/2020_aids-data-book_en.pdf.